Organon
Expanding Reach. Touching More Lives.
With revenues of US$12.4 billion and presence across 140+ markets, Sun Pharma is well positioned to deliver a more comprehensive continuum of care to patients and customers.
Building on the complementary strengths of Sun Pharma and Organon, the focus is on enhancing long term value creation. Discover more about Organon at https://www.organon.com/
No. 3 in Women’s
Health Globally
No. 7 in Biosimilars
Globally
27% Revenue from
Innovative Medicines
55000+ Employees
ברחבי העולם
Better Together
Bigger Together
55,000+ people are committed to serve
healthcare needs of patients and customers
who depend on us, across 140+ countries.
Our growth mindset accelerates strong
brands with scale and operational discipline,
and innovative medicines that address
diverse healthcare needs have access to
newer markets.
Sharper Together
We have relentless focus on customer
centricity, fueled by R&D. Beyond market
leadership in women’s health (top 3),
biosimilars (top 7), we have strong growth
opportunities across cardiology, CNS,
respiratory, dermatology, cutaneous
oncology portfolios.
Closer Together
With 24,000+ commercial front
end people,
we are closer to our customers than before.
We are where our customers are our
combined manufacturing footprint across
five continents makes us a part of more
communities, ensuring that products reach
people who need them. Our people can
access more markets, more products, more
career paths.